2B53.Z

ICD-11 MMS 2026-01

Fibroblastic or myofibroblastic tumour, primary site, unspecified

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Exclusions from above levels

  • 2A01.1 – Mesenchymal tumour of meninges
  • 2A02.1 – Tumours of cranial or paraspinal nerves
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
Show allHide
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2B53.0 – Myxofibrosarcoma, primary site
  • 2B53.1 – Fibroblastic or myofibroblastic tumour of skin
  • 2B53.Y – Other specified fibroblastic or myofibroblastic tumour, primary site

Foundation entity

Fibroblastic or myofibroblastic tumour, primary site – http://id.who.int/icd/entity/1100526834

Allowed postcoordination axes

Part of: 2B53: Fibroblastic or myofibroblastic tumour, primary site › 02: Neoplasms